• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Search 
    •   QMRO Home
    • Blizard Institute
    • Search
    •   QMRO Home
    • Blizard Institute
    • Search
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CommunityBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Discover

    Author
    Foster, GR (103)
    Agarwal, K (21)Gill, US (11)Brainard, DM (10)Alazawi, W (9)Asselah, T (9)Zeuzem, S (9)Barnes, E (8)Dore, GJ (8)Feld, JJ (8)... View MoreSubjectHepatitis C virus (8)Female (6)Hepatitis C (6)Humans (6)Male (6)Adult (5)Antiviral Agents (5)hepatitis C (5)Middle Aged (5)Aged (4)... View MoreDate Issued2020 - 2022 (7)2010 - 2019 (95)2004 - 2009 (1)
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 103

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact 

    Martin, NK; Foster, GR; Vilar, J; Ryder, S; Cramp, ME; Gordon, F; Dillon, JF; Craine, N; Busse, H; Clements, A;... (2015-04)
    Thumbnail

    Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection 

    Agarwal, K; Fung, SK; Nguyen, TT; Cheng, W; Sicard, E; Ryder, SD; Flaherty, JF; Lawson, E; Zhao, S; Subramanian, GM;... (2015-03)
    Thumbnail

    Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection. 

    Agarwal, K; Fung, SK; Nguyen, TT; Cheng, W; Sicard, E; Ryder, SD; Flaherty, JF; Lawson, E; Zhao, S; Subramanian, GM;... (2015-03)
    BACKGROUND & AIMS: Tenofovir alafenamide, a phosphonate prodrug of tenofovir with greater plasma stability than tenofovir disoproxil fumarate, provides efficient delivery of active drug to hepatocytes at reduced systemic ...
    Thumbnail

    Development and Validation of a "Capture-Fusion" Model to Study Drug Sensitivity of Patient-Derived Hepatitis C 

    Cunningham, ME; Javaid, A; Waters, J; Davidson-Wright, J; Wong, JLC; Jones, M; Foster, GR (2015-04)
    Thumbnail

    Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review 

    Owiti, JA; Greenhalgh, T; Sweeney, L; Foster, GR; Bhui, KS (2015-02-15)
    Thumbnail

    INDUCTION MAINTENANCE THERAPY IN CHRONIC HEPATITIS B; STEP-DOWN FROM COMBINATION LAMIVUDINE AND TENOFOVIR TO LAMIVUDINE MONOTHERAPY - A POTENTIAL NEW TREATMENT STRATEGY 

    Gill, US; Payaniandy, L; Payaniandy, D; Schulz, J; Ross, VA; Kallis, YN; Kooner, P; Marley, RTC; Kennedy, PTF; Foster, GR (2013-04)
    Thumbnail

    Functional innate immune responses are restored with sequential NUC therapy following Pegylated Interferon-Alpha exposure and not with NUC monotherapy in Chronic Hepatitis B 

    Gill, US; Peppa, D; Singh, HD; Micco, L; Foster, GR; Maini, MK; Kennedy, PT (2014)
    Thumbnail

    High prevalence of hepatitis C (HCV) in the emergency department (ED) of a London hospital: should we be screening for HCV in ED attendees? 

    Orkin, C; Leach, E; Flanagan, S; Wallis, E; Ruf, M; Foster, GR; Tong, CYW (2015-10)
    Thumbnail

    High levels of Hepatitis B surface antigen (HBsAg) can exclude significant fibrosis and distinguishes true 'immune-tolerance' in children and young adults with Chronic Hepatitis B 

    Hansi, NK; Gill, US; Banerjee, A; Surendraraj, N; Patel, C; Naik, S; Foster, GR; Kennedy, PT (2014)
    Thumbnail

    Shorter treatments for hepatitis C: another step forward? 

    Foster, GR (2015-03-21)
    • 1
    • 2
    • 3
    • 4
    • . . .
    • 11
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.